{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T21:54:19Z","timestamp":1767909259591,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1245\/s10434-021-09927-7","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T15:52:40Z","timestamp":1618501960000},"page":"4130-4137","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The Landmark Series: Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS\/HIPEC) for Treatment of Gastric Cancer Metastatic to Peritoneum"],"prefix":"10.1245","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2012-2238","authenticated-orcid":false,"given":"Sean P.","family":"Dineen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose M.","family":"Pimiento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,15]]},"reference":[{"issue":"6","key":"9927_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin."},{"issue":"13","key":"9927_CR2","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1245\/s10434-016-5409-7","volume":"23","author":"N Ikoma","year":"2016","unstructured":"Ikoma N, Blum M, Chiang YJ, et al. Yield of staging laparoscopy and lavage cytology for radiologically occult peritoneal carcinomatosis of gastric cancer. Ann Surg Oncol. 2016;23(13):4332\u20137.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"9927_CR3","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.jamcollsurg.2014.03.062","volume":"219","author":"G Spolverato","year":"2014","unstructured":"Spolverato G, Ejaz A, Kim Y, et al. Rates and patterns of recurrence after curative intent resection for gastric cancer: a United States multi-institutional analysis. J Am Coll Surg. 2014;219(4):664\u201375.","journal-title":"J Am Coll Surg."},{"issue":"1","key":"9927_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13045-017-0517-9","volume":"10","author":"B Badgwell","year":"2017","unstructured":"Badgwell B, Das P, Ajani J. Treatment of localized gastric and gastroesophageal adenocarcinoma: the role of accurate staging and preoperative therapy. J Hematol Oncol. 2017;10(1):149.","journal-title":"J Hematol Oncol."},{"issue":"5","key":"9927_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1245\/ASO.2005.03.065","volume":"12","author":"D Bentrem","year":"2005","unstructured":"Bentrem D, Wilton A, Mazumdar M, Brennan M, Coit D. The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection. Ann Surg Oncol. 2005;12(5):347\u201353.","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"9927_CR6","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.3748\/wjg.v22.i5.1859","volume":"22","author":"YF Hu","year":"2016","unstructured":"Hu YF, Deng ZW, Liu H, et al. Staging laparoscopy improves treatment decision-making for advanced gastric cancer. World J Gastroenterol. 2016;22(5):1859\u201368.","journal-title":"World J Gastroenterol."},{"issue":"10","key":"9927_CR7","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.6004\/jnccn.2016.0137","volume":"14","author":"JA Ajani","year":"2016","unstructured":"Ajani JA, D\u2019Amico TA, Almhanna K, et al. Gastric cancer, version 3.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2016;14(10):1286\u2013312.","journal-title":"J Natl Compr Canc Netw."},{"issue":"12","key":"9927_CR8","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1093\/annonc\/mdt401","volume":"24","author":"N Bernards","year":"2013","unstructured":"Bernards N, Creemers GJ, Nieuwenhuijzen GA, Bosscha K, Pruijt JF, Lemmens VE. No improvement in median survival for patients with metastatic gastric cancer despite increased use of chemotherapy. Ann Oncol. 2013;24(12):3056\u201360.","journal-title":"Ann Oncol."},{"issue":"3","key":"9927_CR9","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ijc.28373","volume":"134","author":"I Thomassen","year":"2014","unstructured":"Thomassen I, van Gestel YR, van Ramshorst B, et al. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer. 2014;134(3):622\u20138.","journal-title":"Int J Cancer."},{"key":"9927_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.21037\/tgh.2016.08.03","volume":"1","author":"ZH Ji","year":"2016","unstructured":"Ji ZH, Peng KW, Li Y. Intraperitoneal free cancer cells in gastric cancer: pathology of peritoneal carcinomatosis and rationale for intraperitoneal chemotherapy\/hyperthermic intraperitoneal chemotherapy in gastric cancer. Transl Gastroenterol Hepatol. 2016;1:69.","journal-title":"Transl Gastroenterol Hepatol."},{"issue":"2","key":"9927_CR11","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/1097-0142(19880115)61:2<232::AID-CNCR2820610205>3.0.CO;2-U","volume":"61","author":"S Koga","year":"1988","unstructured":"Koga S, Hamazoe R, Maeta M, Shimizu N, Murakami A, Wakatsuki T. Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer. 1988;61(2):232\u20137.","journal-title":"Cancer."},{"issue":"1","key":"9927_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/00000658-198807000-00005","volume":"208","author":"S Fujimoto","year":"1988","unstructured":"Fujimoto S, Shrestha RD, Kokubun M, et al. Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg. 1988;208(1):36\u201341.","journal-title":"Ann Surg."},{"issue":"6","key":"9927_CR13","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1245\/s10434-020-08320-0","volume":"27","author":"G Chicago Consensus Working","year":"2020","unstructured":"Chicago Consensus Working G. The Chicago Consensus on peritoneal surface malignancies: management of gastric metastases. Ann Surg Oncol. 2020;27(6):1768\u201373.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"9927_CR14","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S1055-3207(03)00035-8","volume":"12","author":"Y Yonemura","year":"2003","unstructured":"Yonemura Y, Bandou E, Kinoshita K, et al. Effective therapy for peritoneal dissemination in gastric cancer. Surg Oncol Clin N Am. 2003;12(3):635\u201348.","journal-title":"Surg Oncol Clin N Am."},{"issue":"3","key":"9927_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S1470-2045(15)00553-7","volume":"17","author":"K Fujitani","year":"2016","unstructured":"Fujitani K, Yang HK, Mizusawa J, et al. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial. Lancet Oncol. 2016;17(3):309\u201318.","journal-title":"Lancet Oncol."},{"issue":"11","key":"9927_CR16","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1046\/j.1365-2168.2002.02220.x","volume":"89","author":"HH Hartgrink","year":"2002","unstructured":"Hartgrink HH, Putter H, Klein Kranenbarg E, Bonenkamp JJ, van de Velde CJ, Dutch Gastric Cancer G. Value of palliative resection in gastric cancer. Br J Surg. 2002;89(11):1438\u201343.","journal-title":"Br J Surg"},{"issue":"9","key":"9927_CR17","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1001\/jamaoncol.2017.0515","volume":"3","author":"SE Al-Batran","year":"2017","unstructured":"Al-Batran SE, Homann N, Pauligk C, et al. Effect of neoadjuvant chemotherapy followed by surgical resection on survival in patients with limited metastatic gastric or gastroesophageal junction cancer: the AIO-FLOT3 trial. JAMA Oncol. 2017;3(9):1237\u201344.","journal-title":"JAMA Oncol."},{"issue":"19","key":"9927_CR18","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1200\/JCO.2018.77.8613","volume":"36","author":"H Ishigami","year":"2018","unstructured":"Ishigami H, Fujiwara Y, Fukushima R, et al. Phase III trial comparing intraperitoneal and intravenous paclitaxel plus S-1 versus cisplatin plus S-1 in patients with gastric cancer with peritoneal metastasis: PHOENIX-GC Trial. J Clin Oncol. 2018;36(19):1922\u20139.","journal-title":"J Clin Oncol."},{"issue":"4","key":"9927_CR19","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3322\/caac.21277","volume":"65","author":"LA Lambert","year":"2015","unstructured":"Lambert LA. Looking up: recent advances in understanding and treating peritoneal carcinomatosis. CA Cancer J Clin. 2015;65(4):284\u201398.","journal-title":"CA Cancer J Clin."},{"issue":"6","key":"9927_CR20","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","volume":"18","author":"XJ Yang","year":"2011","unstructured":"Yang XJ, Huang CQ, Suo T, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol. 2011;18(6):1575\u201381.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"9927_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/jso.23633","volume":"110","author":"U Rudloff","year":"2014","unstructured":"Rudloff U, Langan RC, Mullinax JE, et al. Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial. J Surg Oncol. 2014;110(3):275\u201384.","journal-title":"J Surg Oncol."},{"issue":"9","key":"9927_CR22","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1245\/s10434-010-1039-7","volume":"17","author":"O Glehen","year":"2010","unstructured":"Glehen O, Gilly FN, Arvieux C, et al. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol. 2010;17(9):2370\u20137.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"9927_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10120-019-00978-0","volume":"23","author":"B Rau","year":"2020","unstructured":"Rau B, Brandl A, Piso P, et al. Peritoneal metastasis in gastric cancer: results from the German database. Gastric Cancer. 2020;23(1):11\u201322.","journal-title":"Gastric Cancer."},{"issue":"11","key":"9927_CR24","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/j.ejso.2018.06.036","volume":"44","author":"C Rihuete Caro","year":"2018","unstructured":"Rihuete Caro C, Manzanedo I, Pereira F, Carrion-Alvarez L, Serrano A, Perez-Viejo E. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with gastric cancer and peritoneal carcinomatosis. Eur J Surg Oncol. 2018;44(11):1805\u201310.","journal-title":"Eur J Surg Oncol."},{"issue":"6","key":"9927_CR25","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1002\/cam4.2204","volume":"8","author":"R Yarema","year":"2019","unstructured":"Yarema R, Mielko J, Fetsych T, et al. Hyperthermic intraperitoneal chemotherapy (HIPEC) in combined treatment of locally advanced and intraperitonealy disseminated gastric cancer: A retrospective cooperative Central-Eastern European study. Cancer Med. 2019;8(6):2877\u201385.","journal-title":"Cancer Med."},{"issue":"11","key":"9927_CR26","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1245\/s10434-017-6047-4","volume":"24","author":"B Badgwell","year":"2017","unstructured":"Badgwell B, Blum M, Das P, et al. Phase II trial of laparoscopic hyperthermic intraperitoneal chemoperfusion for peritoneal carcinomatosis or positive peritoneal cytology in patients with gastric adenocarcinoma. Ann Surg Oncol. 2017;24(11):3338\u201344.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"9927_CR27","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1245\/s10434-020-08739-5","volume":"28","author":"B Badgwell","year":"2021","unstructured":"Badgwell B, Ikoma N, Murphy MB, et al. A phase II trial of cytoreduction, gastrectomy, and hyperthermic intraperitoneal perfusion with chemotherapy for patients with gastric cancer and carcinomatosis or positive cytology. Ann Surg Oncol. 2021;28(1):258\u201364.","journal-title":"Ann Surg Oncol."},{"issue":"11","key":"9927_CR28","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1002\/bjs.11588","volume":"107","author":"RT van der Kaaij","year":"2020","unstructured":"van der Kaaij RT, Wassenaar ECE, Koemans WJ, et al. Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and\nhyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results. Br J Surg. 2020;107(11):1520\u201328.","journal-title":"Br J Surg."},{"issue":"23","key":"9927_CR29","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1200\/JCO.18.01688","volume":"37","author":"PE Bonnot","year":"2019","unstructured":"Bonnot PE, Piessen G, Kepenekian V, et al. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis. J Clin Oncol. 2019;37(23):2028\u201340.","journal-title":"J Clin Oncol."},{"issue":"1","key":"9927_CR30","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ejso.2020.10.006","volume":"47","author":"A Brandl","year":"2021","unstructured":"Brandl A, Yonemura Y, Glehen O, Sugarbaker P, Rau B. Long term survival in patients with peritoneal metastasised gastric cancer treated with cytoreductive surgery and HIPEC: a multi-institutional cohort from PSOGI. Eur J Surg Oncol. 2021;47(1):172\u201380.","journal-title":"Eur J Surg Oncol."},{"issue":"1","key":"9927_CR31","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s12885-019-5640-2","volume":"19","author":"WJ Koemans","year":"2019","unstructured":"Koemans WJ, van der Kaaij RT, Boot H, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II). BMC Cancer. 2019;19(1):420.","journal-title":"BMC Cancer."},{"issue":"1","key":"9927_CR32","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1186\/s12885-017-3918-9","volume":"17","author":"SE Al-Batran","year":"2017","unstructured":"Al-Batran SE, Goetze TO, Mueller DW, et al. The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction\u2014a phase III trial of the German AIO\/CAO-V\/CAOGI. BMC Cancer. 2017;17(1):893.","journal-title":"BMC Cancer."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-09927-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-09927-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-09927-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T16:22:48Z","timestamp":1625242968000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-09927-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,15]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["9927"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-09927-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,15]]},"assertion":[{"value":"23 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}